Arkolith/Insider Trading/PBYI/Form 4

Auerbach Alan H

President and CEO, Director, 10% OwnerPUMA BIOTECHNOLOGY, INC. (PBYI) · full profile →Form 4 · filed Jan 3, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$107K
Net Open-Market Flow
-$107K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 2, 2025Sell(S)34K$3.15$107K7.0M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-25-000359) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML